Trellus Health plc (TRLS) ORD GBP0.0006
- Add to watchlist
- Create an alert
- This stock can be held in a
Business summary
Trellus Health plc is a United Kingdom-based digital health company. It offers a scientifically validated, personalized resilience-based self-management training program for people living with chronic conditions. It is focused on the intersection of chronic physical conditions and mental health. The Company’s approach transforms chronic disease management and changes the lives of patients living with debilitating, incurable conditions, primarily focused on inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis, and irritable bowel syndrome (IBS). The TrellusElevate platform is the Company's connected health platform that incorporates the Gaining Resilience Through Transitions (GRITT) methodology and learnings on resilience from clinical research and practice. Through its TrellusElevate connected care platform and companion App, the Company addresses both clinical and behavioral health together. The Company’s wholly owned subsidiary is Trellus Health Inc.
Contact details
Important dates
General stock information
- EPIC:
- TRLS
- ISIN:
- GB00BNNFM402
- Market cap:
- £3.07 million
- Shares in issue:
- 161.51 million
- Sector:
- No specific Industry
- Exchange:
- London Stock Exchange
- Currency:
- Sterling pence
- Indices:
- n/a
Key personnel
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.